{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:04:53Z","timestamp":1785816293630,"version":"3.56.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008985","name":"Diab\u00e8te Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008985","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["#20697"],"award-info":[{"award-number":["#20697"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["#20697"],"award-info":[{"award-number":["#20697"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["#20697"],"award-info":[{"award-number":["#20697"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["#MOP 115071"],"award-info":[{"award-number":["#MOP 115071"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["#MOP 115071"],"award-info":[{"award-number":["#MOP 115071"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["#MOP 115071"],"award-info":[{"award-number":["#MOP 115071"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation de ma vie of the CIUSSS du Saguenay\u2013Lac-St-Jean \u2013 H\u00f4pital Universitaire de Chicoutimi"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Gestational hypertension (GH) is linked to an increased risk of cardiometabolic diseases for both mother and child, but we lack reliable biomarkers to identify high-risk women early in pregnancy. MicroRNAs (miRNAs) are small non-coding RNA that have emerged as promising biomarkers for pregnancy complications. We thus aimed to identify first trimester circulating miRNAs associated with GH and to build a miRNA-based algorithm to predict GH incidence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We quantified miRNAs using next-generation sequencing in plasma samples collected at first trimester of pregnancy in Gen3G (<jats:italic>N<\/jats:italic>\u2009=\u2009413, including 28 GH cases) and 3D (<jats:italic>N<\/jats:italic>\u2009=\u2009281, including 21 GH cases) prospective birth cohorts. MiRNAs associated with GH in Gen3G (identified using DESeq2, <jats:italic>p<\/jats:italic>-value\u2009&lt;\u20090.05) and replicated in 3D were included in a stepwise logistic regression model to estimate the probability of developing GH based on the miRNAs (normalized z-score counts) and maternal characteristics that contribute most to the model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We identified 28 miRNAs associated with the onset of GH later in pregnancy (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) in the Gen3G cohort. Among these, three were replicated in the 3D cohort (similar fold change and <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.1) and were included in stepwise logistic regression models with GH-related risk factors. When combined with first trimester mean arterial pressure (MAP), miR-208b-3p and miR-26a-1-3p achieve an AUC of 0.803 (95%CI: 0.512\u20130.895) in Gen3G and 0.709 (95%CI: 0.588\u20130.829) in 3D. The addition of miR-208b-3p, and miR-26a-1-3p to the model significantly improves the prediction performance over that of MAP alone (<jats:italic>p<\/jats:italic>\u2009=\u20090.03). We then proposed low and high-risk thresholds, which could help identify women at very low risk of GH and those who could benefit from prevention monitoring throughout their pregnancy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The combination of circulating miR-208b-3p and miR-26a-1-3p with first trimester MAP offers good performance as early predictors of GH. Interestingly, these miRNAs target pathways related to the cardiovascular system and could thus be relevant to the pathophysiology of GH. These miRNAs thus provide a novel avenue to identify women at risk and could lead to even more adequate obstetrical care to reduce the risk of complications associated with GH.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12884-025-07349-x","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T10:44:47Z","timestamp":1741430687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["First trimester circulating miR-208b-3p and miR-26a-1-3p are relevant to the prediction of gestational hypertension"],"prefix":"10.1186","volume":"25","author":[{"given":"Andr\u00e9e-Anne","family":"Cl\u00e9ment","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cilia","family":"L\u00c9GAR\u00c9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Desgagn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine","family":"Thibeault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-\u00c9tienne","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Perron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e","family":"Gu\u00e9rin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-France","family":"Hivert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"key":"7349_CR1","doi-asserted-by":"publisher","first-page":"e023791","DOI":"10.1161\/JAHA.121.023791","volume":"11","author":"NA Cameron","year":"2022","unstructured":"Cameron NA, Everitt I, Seegmiller LE, Yee LM, Grobman WA, Khan SS. Trends in the incidence of New-Onset hypertensive disorders of pregnancy among rural and urban areas in the united States, 2007 to 2019. J Am Heart Assoc. 2022;11:e023791.","journal-title":"J Am Heart Assoc"},{"key":"7349_CR2","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/1471-0528.16678","volume":"129","author":"E Mulder","year":"2022","unstructured":"Mulder E, Haas S, Mohseni Z, Schartmann N, Abo Hasson F, Alsadah F, et al. Cardiac output and peripheral vascular resistance during normotensive and hypertensive pregnancy \u2013 a systematic review and meta-analysis. BJOG. 2022;129:696\u2013707.","journal-title":"BJOG"},{"key":"7349_CR3","doi-asserted-by":"publisher","first-page":"S988","DOI":"10.1016\/j.ajog.2021.11.022","volume":"226","author":"W Gyselaers","year":"2022","unstructured":"Gyselaers W. Hemodynamic pathways of gestational hypertension and preeclampsia. Am J Obstet Gynecol. 2022;226:S988\u20131005.","journal-title":"Am J Obstet Gynecol"},{"key":"7349_CR4","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1161\/CIRCULATIONAHA.114.009029","volume":"130","author":"M Sanghavi","year":"2014","unstructured":"Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014;130:1003\u20138.","journal-title":"Circulation"},{"key":"7349_CR5","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.jacc.2020.03.028","volume":"75","author":"VD Garovic","year":"2020","unstructured":"Garovic VD, White WM, Vaughan L, Saiki M, Parashuram S, Garcia-Valencia O, et al. Incidence and Long-Term outcomes of hypertensive disorders of pregnancy. J Am Coll Cardiol. 2020;75:2323\u201334.","journal-title":"J Am Coll Cardiol"},{"key":"7349_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12884-021-03809-2","volume":"21","author":"W Wang","year":"2021","unstructured":"Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z, et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and National levels: a population-based study. BMC Pregnancy Childbirth. 2021;21:364.","journal-title":"BMC Pregnancy Childbirth"},{"key":"7349_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/hr.2016.126","volume":"40","author":"M Umesawa","year":"2017","unstructured":"Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40:213\u201320.","journal-title":"Hypertens Res"},{"key":"7349_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 international society for the study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148\u201369.","journal-title":"Pregnancy Hypertens"},{"key":"7349_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.preghy.2019.12.002","volume":"19","author":"LA Magee","year":"2020","unstructured":"Magee LA, Singer J, Lee T, McManus RJ, Lay-Flurrie S, Rey E, et al. Are blood pressure level and variability related to pregnancy outcome? Analysis of control of hypertension in pregnancy study data. Pregnancy Hypertens. 2020;19:87\u201393.","journal-title":"Pregnancy Hypertens"},{"key":"7349_CR10","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.jacc.2022.03.383","volume":"79","author":"LD Levine","year":"2022","unstructured":"Levine LD, Ky B, Chirinos JA, Koshinksi J, Arany Z, Riis V, et al. Prospective evaluation of cardiovascular risk 10 years after a hypertensive disorder of pregnancy. J Am Coll Cardiol. 2022;79:2401\u201311.","journal-title":"J Am Coll Cardiol"},{"key":"7349_CR11","doi-asserted-by":"publisher","first-page":"e008337","DOI":"10.1161\/JAHA.117.008337","volume":"7","author":"HKR Riise","year":"2018","unstructured":"Riise HKR, Sulo G, Tell GS, Igland J, Nyg\u00e5rd O, Iversen A-C, et al. Association between gestational hypertension and risk of cardiovascular disease among 617 589 Norwegian women. J Am Heart Assoc. 2018;7:e008337.","journal-title":"J Am Heart Assoc"},{"key":"7349_CR12","doi-asserted-by":"publisher","first-page":"e013991","DOI":"10.1161\/JAHA.119.013991","volume":"9","author":"CCW Lo","year":"2020","unstructured":"Lo CCW, Lo ACQ, Leow SH, Fisher G, Corker B, Batho O, et al. Future cardiovascular disease risk for women with gestational hypertension: A systematic review and Meta-Analysis. JAHA. 2020;9:e013991.","journal-title":"JAHA"},{"key":"7349_CR13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1056\/NEJM199204023261405","volume":"326","author":"JF Desforges","year":"1992","unstructured":"Desforges JF, Cunningham FG, Lindheimer MD. Hypertension in pregnancy. N Engl J Med. 1992;326:927\u201332.","journal-title":"N Engl J Med"},{"key":"7349_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1404595","volume":"372","author":"LA Magee","year":"2015","unstructured":"Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, et al. Less-Tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372:407\u201317.","journal-title":"N Engl J Med"},{"key":"7349_CR15","doi-asserted-by":"publisher","first-page":"e0230955","DOI":"10.1371\/journal.pone.0230955","volume":"15","author":"E Antwi","year":"2020","unstructured":"Antwi E, Amoakoh-Coleman M, Vieira DL, Madhavaram S, Koram KA, Grobbee DE, et al. Systematic review of prediction models for gestational hypertension and preeclampsia. PLoS ONE. 2020;15:e0230955.","journal-title":"PLoS ONE"},{"key":"7349_CR16","doi-asserted-by":"publisher","first-page":"e0175914","DOI":"10.1371\/journal.pone.0175914","volume":"12","author":"M Shen","year":"2017","unstructured":"Shen M, Smith GN, Rodger M, White RR, Walker MC, Wen SW. Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia. PLoS ONE. 2017;12:e0175914.","journal-title":"PLoS ONE"},{"key":"7349_CR17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1161\/HYPERTENSIONAHA.116.07099","volume":"67","author":"GM Egeland","year":"2016","unstructured":"Egeland GM, Klungs\u00f8yr K, \u00d8yen N, Tell GS, N\u00e6ss \u00d8, Skj\u00e6rven R. Preconception cardiovascular risk factor differences between gestational hypertension and preeclampsia: cohort Norway study. Hypertension. 2016;67:1173\u201380.","journal-title":"Hypertension"},{"key":"7349_CR18","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1161\/ATVBAHA.115.305817","volume":"35","author":"LH Tanger\u00e5s","year":"2015","unstructured":"Tanger\u00e5s LH, Austdal M, Skr\u00e5stad RB, Salvesen K\u00c5, Austgulen R, Bathen TF, et al. Distinct first trimester cytokine profiles for gestational hypertension and preeclampsia. Arterioscler Thromb Vasc Biol. 2015;35:2478\u201385.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7349_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.preghy.2022.10.009","volume":"30","author":"L Ghesquiere","year":"2022","unstructured":"Ghesquiere L, Vachon-Marceau C, Kingdom JC, Ferreira E, C\u00f4t\u00e9 S, Guerby P, et al. Short communication: is there any benefit of initiating aspirin before the 11th week of gestation? Pregnancy Hypertens. 2022;30:189\u201391.","journal-title":"Pregnancy Hypertens"},{"key":"7349_CR20","doi-asserted-by":"publisher","first-page":"S1120","DOI":"10.1016\/j.ajog.2021.10.038","volume":"226","author":"D Wright","year":"2022","unstructured":"Wright D, Wright A, Tan MY, Nicolaides KH. When to give aspirin to prevent preeclampsia: application of bayesian decision theory. Am J Obstet Gynecol. 2022;226:S1120\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"7349_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik DL, Wright D, Poon LC, O\u2019Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613\u201322.","journal-title":"N Engl J Med"},{"key":"7349_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7349_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1095\/biolreprod.108.075481","volume":"81","author":"S-S Luo","year":"2009","unstructured":"Luo S-S, Ishibashi O, Ishikawa G, Ishikawa T, Katayama A, Mishima T, et al. Human villous trophoblasts express and secrete placenta-specific MicroRNAs into maternal circulation via exosomes. Biol Reprod. 2009;81:717\u201329.","journal-title":"Biol Reprod"},{"key":"7349_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/bies.201500130","volume":"38","author":"H Iftikhar","year":"2016","unstructured":"Iftikhar H, Carney GE. Evidence and potential in vivo functions for biofluid MiRNAs: from expression profiling to functional testing: potential roles of extracellular MiRNAs as indicators of physiological change and as agents of intercellular information exchange. BioEssays. 2016;38:367\u201378.","journal-title":"BioEssays"},{"key":"7349_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12958-021-00883-1","volume":"20","author":"C L\u00e9gar\u00e9","year":"2022","unstructured":"L\u00e9gar\u00e9 C, Cl\u00e9ment A-A, Desgagn\u00e9 V, Thibeault K, White F, Guay S-P, et al. Human plasma pregnancy-associated MiRNAs and their Temporal variation within the first trimester of pregnancy. Reprod Biol Endocrinol. 2022;20:14.","journal-title":"Reprod Biol Endocrinol"},{"key":"7349_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11892-017-0856-5","volume":"17","author":"C Poirier","year":"2017","unstructured":"Poirier C, Desgagn\u00e9 V, Gu\u00e9rin R, Bouchard L. MicroRNAs in pregnancy and gestational diabetes mellitus: emerging role in maternal metabolic regulation. Curr Diab Rep. 2017;17:35.","journal-title":"Curr Diab Rep"},{"key":"7349_CR27","doi-asserted-by":"crossref","unstructured":"Hromadnikova I, Dvorakova L, Kotlabova K, Krofta L. The prediction of gestational hypertension, preeclampsia and fetal growth restriction via the first trimester screening of plasma Exosomal C19MC MicroRNAs. Int J Mol Sci. 2019;20(12):2972.","DOI":"10.3390\/ijms20122972"},{"key":"7349_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.thromres.2015.11.032","volume":"137","author":"I Hromadnikova","year":"2016","unstructured":"Hromadnikova I, Kotlabova K, Hympanova L, Krofta L. Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated MicroRNAs in maternal whole peripheral blood. Thromb Res. 2016;137:126\u201340.","journal-title":"Thromb Res"},{"key":"7349_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/6972732","volume":"2017","author":"M Cai","year":"2017","unstructured":"Cai M, Kolluru GK, Ahmed A, Small Molecule. Big prospects: MicroRNA in pregnancy and its complications. J Pregnancy. 2017;2017:1\u201315.","journal-title":"J Pregnancy"},{"key":"7349_CR30","doi-asserted-by":"publisher","first-page":"928508","DOI":"10.3389\/fendo.2022.928508","volume":"13","author":"C L\u00e9gar\u00e9","year":"2022","unstructured":"L\u00e9gar\u00e9 C, Desgagn\u00e9 V, Thibeault K, White F, Cl\u00e9ment A-A, Poirier C, et al. First trimester plasma MicroRNA levels predict risk of developing gestational diabetes mellitus. Front Endocrinol. 2022;13:928508.","journal-title":"Front Endocrinol"},{"key":"7349_CR31","doi-asserted-by":"publisher","first-page":"e010031","DOI":"10.1136\/bmjopen-2015-010031","volume":"6","author":"L Guillemette","year":"2016","unstructured":"Guillemette L, Allard C, Lacroix M, Patenaude J, Battista M-C, Doyon M, et al. Genetics of glucose regulation in gestation and growth (Gen3G): a prospective prebirth cohort of mother\u2013child pairs in Sherbrooke, Canada. BMJ Open. 2016;6:e010031.","journal-title":"BMJ Open"},{"key":"7349_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/ppe.12320","volume":"30","author":"WD Fraser","year":"2016","unstructured":"Fraser WD, Shapiro GD, Audibert F, Dubois L, Pasquier J, Julien P, et al. 3D cohort study: the integrated research network in perinatology of Quebec and Eastern Ontario. Paediatr Perinat Epidemiol. 2016;30:623\u201332.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"7349_CR33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","volume":"44","author":"LA Magee","year":"2022","unstructured":"Magee LA, Smith GN, Bloch C, C\u00f4t\u00e9 A-M, Jain V, Nerenberg K, et al. Guideline 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management. J Obstet Gynecol Can. 2022;44:547\u2013e5711.","journal-title":"J Obstet Gynecol Can"},{"key":"7349_CR34","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc09-1848","volume":"33","author":"International Association of Diabetes and Pregnancy Study Groups Consensus Panel","year":"2010","unstructured":"International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676\u201382.","journal-title":"Diabetes Care"},{"key":"7349_CR35","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1161\/HYPERTENSIONAHA.107.104646","volume":"51","author":"LCY Poon","year":"2008","unstructured":"Poon LCY, Kametas NA, Pandeva I, Valencia C, Nicolaides KH. Mean arterial pressure at 11+\u20090 to 13+\u20096 weeks in the prediction of preeclampsia. Hypertension. 2008;51:1027\u201333.","journal-title":"Hypertension"},{"key":"7349_CR36","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1161\/HYPERTENSIONAHA.114.03578","volume":"64","author":"LC Kenny","year":"2014","unstructured":"Kenny LC, Black MA, Poston L, Taylor R, Myers JE, Baker PN, et al. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the screening for pregnancy endpoints (SCOPE) international cohort study. Hypertension. 2014;64:644\u201352.","journal-title":"Hypertension"},{"key":"7349_CR37","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1261\/rna.036863.112","volume":"19","author":"KL Burgos","year":"2013","unstructured":"Burgos KL, Javaherian A, Bomprezzi R, Ghaffari L, Rhodes S, Courtright A, et al. Identification of extracellular MiRNA in human cerebrospinal fluid by next-generation sequencing. RNA. 2013;19:712\u201322.","journal-title":"RNA"},{"key":"7349_CR38","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cels.2019.03.004","volume":"8","author":"J Rozowsky","year":"2019","unstructured":"Rozowsky J, Kitchen RR, Park JJ, Galeev TR, Diao J, Warrell J, et al. ExceRpt: A comprehensive analytic platform for extracellular RNA profiling. Cell Syst. 2019;8:352\u2013e3573.","journal-title":"Cell Syst"},{"key":"7349_CR39","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S. MiRBase: from MicroRNA sequences to function. Nucleic Acids Res. 2019;47:D155\u201362.","journal-title":"Nucleic Acids Res"},{"key":"7349_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"7349_CR41","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"7349_CR42","unstructured":"Blighe K, Rana S, Lewis M, EnhancedVolcano. Publication-ready volcano plots with enhanced colouring and labeling. 2020."},{"key":"7349_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"key":"7349_CR44","unstructured":"L\u00fcdecke D. sjPlot - Data Visualization for Statistics in Social Science. 2018."},{"key":"7349_CR45","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. 2013."},{"key":"7349_CR46","unstructured":"RStudio Team. RStudio: Integrated Development for R. RStudio. 2020."},{"key":"7349_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jri.2015.09.003","volume":"112","author":"L Guillemette","year":"2015","unstructured":"Guillemette L, Lacroix M, Allard C, Patenaude J, Battista M-C, Doyon M, et al. Preeclampsia is associated with an increased pro-inflammatory profile in newborns. J Reprod Immunol. 2015;112:111\u20134.","journal-title":"J Reprod Immunol"},{"key":"7349_CR48","doi-asserted-by":"crossref","unstructured":"Zhu X, Han T, Sargent IL, Yin G, Yao Y. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. American Journal of Obstetrics and Gynecology. 2009;200:661.e1-661.e7.","DOI":"10.1016\/j.ajog.2008.12.045"},{"key":"7349_CR49","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cellsig.2018.12.006","volume":"55","author":"R Li","year":"2019","unstructured":"Li R, Wang N, Xue M, Long W, Cheng C, Mi C, et al. A potential regulatory network among WDR86-AS1, miR-10b-3p, and LITAF is possibly involved in preeclampsia pathogenesis. Cell Signal. 2019;55:40\u201352.","journal-title":"Cell Signal"},{"key":"7349_CR50","doi-asserted-by":"publisher","first-page":"6399","DOI":"10.3892\/mmr.2015.4243","volume":"12","author":"J Zou","year":"2015","unstructured":"Zou J, Guo P, Lv N, Huang D. Lipopolysaccharide-induced tumor necrosis factor-\u03b1 factor enhances inflammation and is associated with cancer (Review). Mol Med Rep. 2015;12:6399\u2013404.","journal-title":"Mol Med Rep"},{"key":"7349_CR51","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/CIRCGENETICS.110.957415","volume":"3","author":"MF Corsten","year":"2010","unstructured":"Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, et al. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet. 2010;3:499\u2013506.","journal-title":"Circ Cardiovasc Genet"},{"key":"7349_CR52","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.yjmcc.2016.08.012","volume":"99","author":"S Ca\u00f1\u00f3n","year":"2016","unstructured":"Ca\u00f1\u00f3n S, Caballero R, Herraiz-Mart\u00ednez A, P\u00e9rez-Hern\u00e1ndez M, L\u00f3pez B, Atienza F, et al. miR-208b upregulation interferes with calcium handling in HL-1 atrial myocytes: implications in human chronic atrial fibrillation. J Mol Cell Cardiol. 2016;99:162\u201373.","journal-title":"J Mol Cell Cardiol"},{"key":"7349_CR53","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s13105-015-0409-9","volume":"71","author":"Y Huang","year":"2015","unstructured":"Huang Y, Li J. MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker. J Physiol Biochem. 2015;71:479\u201386.","journal-title":"J Physiol Biochem"},{"key":"7349_CR54","first-page":"D148","volume":"48","author":"H-Y Huang","year":"2020","unstructured":"Huang H-Y, Lin Y-C-D, Li J, Huang K-Y, Shrestha S, Hong H-C, et al. MiRTarBase 2020: updates to the experimentally validated microRNA-target interaction database. Nucleic Acids Res. 2020;48:D148\u201354.","journal-title":"Nucleic Acids Res"},{"key":"7349_CR55","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/00004872-198410000-00002","volume":"2","author":"BF Robinson","year":"1984","unstructured":"Robinson BF. Altered calcium handling as a cause of primary hypertension. J Hypertens. 1984;2:453\u201360.","journal-title":"J Hypertens"},{"key":"7349_CR56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/1074248414555403","volume":"20","author":"G Tocci","year":"2015","unstructured":"Tocci G, Battistoni A, Passerini J, Musumeci MB, Francia P, Ferrucci A, et al. Calcium channel blockers and hypertension. J Cardiovasc Pharmacol Ther. 2015;20:121\u201330.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"7349_CR57","doi-asserted-by":"publisher","first-page":"239821281879480","DOI":"10.1177\/2398212818794805","volume":"2","author":"AC Dolphin","year":"2018","unstructured":"Dolphin AC. Voltage-gated calcium channels: their discovery, function and importance as drug targets. Brain Neurosci Adv. 2018;2:239821281879480.","journal-title":"Brain Neurosci Adv"},{"key":"7349_CR58","doi-asserted-by":"publisher","first-page":"9401","DOI":"10.1038\/srep09401","volume":"5","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Qin W, Zhang L, Wu X, Du N, Hu Y, et al. MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis. Sci Rep. 2015;5:9401.","journal-title":"Sci Rep"},{"key":"7349_CR59","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.tcm.2014.06.003","volume":"24","author":"B Icli","year":"2014","unstructured":"Icli B, Dorbala P, Feinberg MW. An emerging role for the miR-26 family in cardiovascular disease. Trends Cardiovasc Med. 2014;24:241\u20138.","journal-title":"Trends Cardiovasc Med"},{"key":"7349_CR60","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/FJC.0b013e31829b82e6","volume":"62","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Li J, Liu B, Luo C, Dong Q, Zhao L, et al. MicroRNA-26 was decreased in rat cardiac hypertrophy model and May be a promising therapeutic target. J Cardiovasc Pharmacol. 2013;62:312\u20139.","journal-title":"J Cardiovasc Pharmacol"},{"key":"7349_CR61","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1172\/JCI62185","volume":"123","author":"X Luo","year":"2013","unstructured":"Luo X, Pan Z, Shan H, Xiao J, Sun X, Wang N, et al. MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J Clin Invest. 2013;123:1939\u201351.","journal-title":"J Clin Invest"},{"key":"7349_CR62","first-page":"e004888","volume":"9","author":"JS Castleman","year":"2016","unstructured":"Castleman JS, Ganapathy R, Taki F, Lip GYH, Steeds RP, Kotecha D. Echocardiographic structure and function in hypertensive disorders of pregnancy: A systematic review. Circ: Cardiovasc Imaging. 2016;9:e004888.","journal-title":"Circ: Cardiovasc Imaging"},{"key":"7349_CR63","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u201333.","journal-title":"Cell"},{"key":"7349_CR64","doi-asserted-by":"publisher","first-page":"981152","DOI":"10.3389\/fphar.2022.981152","volume":"13","author":"GH-H Chan","year":"2022","unstructured":"Chan GH-H, Chan E, Kwok CT-K, Leung GP-H, Lee SM-Y, Seto S-W. The role of p53 in the alternation of vascular functions. Front Pharmacol. 2022;13:981152.","journal-title":"Front Pharmacol"},{"key":"7349_CR65","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00018-020-03694-6","volume":"78","author":"H Men","year":"2021","unstructured":"Men H, Cai H, Cheng Q, Zhou W, Wang X, Huang S, et al. The regulatory roles of p53 in cardiovascular health and disease. Cell Mol Life Sci. 2021;78:2001\u201318.","journal-title":"Cell Mol Life Sci"},{"key":"7349_CR66","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1093\/nar\/gkw550","volume":"44","author":"X Lai","year":"2016","unstructured":"Lai X, Wolkenhauer O, Vera J. Understanding microRNA-mediated gene regulatory networks through mathematical modelling. Nucleic Acids Res. 2016;44:6019\u201335.","journal-title":"Nucleic Acids Res"},{"key":"7349_CR67","first-page":"1","volume":"2013","author":"I Hromadnikova","year":"2013","unstructured":"Hromadnikova I, Kotlabova K, Ondrackova M, Kestlerova A, Novotna V, Hympanova L, et al. Circulating C19MC MicroRNAs in preeclampsia, gestational hypertension, and fetal growth restriction. Mediat Inflamm. 2013;2013:1\u201312.","journal-title":"Mediat Inflamm"},{"key":"7349_CR68","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1530\/JOE-16-0340","volume":"232","author":"DS Boeldt","year":"2017","unstructured":"Boeldt DS, Bird IM. Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia. J Endocrinol. 2017;232:R27\u201344.","journal-title":"J Endocrinol"},{"key":"7349_CR69","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/10641955.2015.1090581","volume":"34","author":"S Shahul","year":"2015","unstructured":"Shahul S, Tung A, Minhaj M, Nizamuddin J, Wenger J, Mahmood E, et al. Racial disparities in comorbidities, complications, and maternal and fetal outcomes in women with preeclampsia\/eclampsia. Hypertens Pregnancy. 2015;34:506\u201315.","journal-title":"Hypertens Pregnancy"},{"key":"7349_CR70","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino","year":"2008","unstructured":"D\u2019Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation. 2008;117:743\u201353.","journal-title":"Circulation"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07349-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07349-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07349-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T11:23:33Z","timestamp":1741433013000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-07349-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,8]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7349"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07349-x","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,8]]},"assertion":[{"value":"30 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study and all methods were carried out in accordance with the Declaration of Helsinki. The study and all experiments protocol were approved by the Institutional Review Board of CIUSSS de l\u2019Estrie-CHUS (Gen3G cohort; reference number MP-31-2019-3059) and the Research ethics committee of the Sainte-Justine University Hospital Centre (3D cohort; reference number CHU-HSJ-2009-010). Written informed consent was provided by all participants involved in the study for both Gen3G and 3D prospective birth cohorts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}